Sched.com Conference Mobile Apps
DIA 2020 Virtual Global Annual Meeting
has ended
Create Your Own Event
DIA 2020 Virtual Global Annual Meeting
-
Saved To
My Schedule
Schedule
Simple
Expanded
Grid
By Venue
Speakers
Search
or browse by date + venue
00: Plenary
All
Forum
01: ClinSafety-PV
All
Forum
Session
Tutorial
Workshop
02: ClinTrials -ClinOps
All
Forum
Session
Tutorial
Workshop
03: Data-Data Standards
All
Forum
Session
Tutorial
Workshop
04: MedAffairs-SciComm
All
Forum
Session
Workshop
05: Patient Engagement
All
Forum
Session
Workshop
06: PreClin Dev-EarlyPhaseCR
All
Forum
Session
07: ProjMgt-StrategicPlanning
All
Forum
Session
Tutorial
08: R-D Quality-Compliance
All
Forum
Session
Tutorial
Workshop
09: Regulatory
All
Forum
Session
Tutorial
Workshop
10: RegCMC-Product Quality
All
Forum
Session
11: Statistics
All
Forum
Session
Workshop
12: Value-Access
All
Forum
Session
13: ProfDevelopment
All
Forum
Session
Tutorial
Workshop
16: Content Hubs
All
Workshop
17: Community Rounds
All
Forum
18: InnovTheater
All
Session
19: Posters
All
Poster Presentation
20: DIAmond
All
Forum
21: Networking-CommunityEvents
All
Session
Short Courses
All
Tutorial
LEVEL
Advanced
Beginner
Intermediate
FEATURED TOPICS
Advanced Therapeutics
Artificial Intelligence
COVID 19 - Pandemic
Data Science
Digital Technology
HTA
ICH
Innovative Trial Design
Patient Focused
Real World Evidence
Regulator Thinking
Student Programming
What's Next
menu
Menu
Log in
Sign up
Schedule
Speakers
Search
Danielle Abatemarco
Bristol Myers Squibb
WWPS Innovation & Publications Management
SA
Stephanie Abbott
Western Washington Medical Group
Director of Research
Anna Adams
Medicines and Healthcare products Regulatory Agency (MHRA)
Senior GPvP Inspector, Inspection, Enforcement and Standards
AA
Adebola Adedimeji
Albert Einstein College of Medicine
Associate Professor of Epidemiology and Population Health
Joan Affleck
Merck & Co., Inc.
Executive Director, Head of Medical Writing
Kaia Agarwal
PharmApprove, A Member of the NDA Group
Strategic Lead
Dean Aguiar
Tuberous Sclerosis Alliance
Director, Preclinical Research
Shazia Ahmad
UBC, United States
Senior Director, Patient and Physician Services
IA
Imad Al-Dakkak
Huron Consulting Group
Director
Rinol Alaj
TransCelerate Biopharmaceuticals
Director, COA and Innovation, Regeneron; Representative
AA
Albert Allen
Eli Lilly and Company, United States
Senior Medical Fellow, Pediatric Capabilities
Jeff Allen
Friends of Cancer Research, United States
President and Chief Executive Officer
Mitzi Allred
Merck & Co., Inc., United States
Director, Clinical Operations
Dawn Anderson
Deloitte, United States
Managing Director, Life Sciences
Jonathan Andrus
Clinical Research IO (CRIO), United States
President and Chief Operating Officer
Kristin Anthony
PTEN Hamartoma Tumor Syndrome Foundation
President
Yoko Aoi
Pharmaceuticals and Medical Devices Agency (PMDA)
Principal reviewer, Office of New Drug V
John April
Eli Lilly and Company, United States
Senior Director, Adaptive Content Strategy, Global Scientific...
Hiroyuki Arai
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Executive Director
RR
Rajeswara Rao Arasada
The Ohio State University
MACPR Student
CA
Christine Årdal
Norwegian Institute of Public Health
Senior Advisor
Lauri Arnstein
Envision Pharma Group
Patient Partnership Liaison
Vinod Arora
Bridge Medical Consulting Pvt. Ltd, India
Lead- Portfolio Management
Stacey Arrambide
Advanced Clinical, United States
Senior Vice President, Functional Service Solutions
Christopher Austin
National Institutes of Health (NIH)
Director, National Center for Advancing Translational Sciences
Mark Avigan
FDA
Associate Director, Office of Pharmacovigilance and Epidemiology,...
Kassa Ayalew
FDA, United States
Director, DCCE, OSI, Office of Compliance, CDER
Ryan Baehl
Covance
Vice President of Global Operations for CLS
PB
Pavel Balabanov
European Medicines Agency
Head of Therapies for Neurological and Psychiatric Disorders
Venkatraman Balasubramanian
Orion Innovation, United States
SVP and Global Head, Industry Solutions - Healthcare and Life Sciences
Matt Baldwin
Advance Research Associates, Inc (ARA), United States
Senior Biostatistician
Greg Ball
Global Vaccine Safety, Novavax, Inc., United States
Head of Safety Statistics
Phil Ball
Independent Consultant
Health Policy, Biopharmaceutical Development Strategy
Deepak Bandyopadhyay
Janssen, United States
Interim Head, Quality Analytics Data Sciences
Mark Barnes
Ropes & Gray, LLP
Partner
Carla Barrett
PRA Health Sciences
Sr Director, Patient Safety Risk Mgmt
Merith Basey
Universities Allied For Essential Medicines (UAEM)
Executive Director, North America
Marilena Bassi
Health Canada
Senior Executive Director, Therapeutic Products Directorate
Steven Beales
WIRB-Copernicus Group (WCG)
Senior Vice President, Scientific and Regulatory Review
Steven Beales
WCG
Senior Vice President, Scientific & Regulatory Review
Matt Becker
SAS Institute Inc., United States
Life Science Strategic Advisor
Emmanuel Belabe
ArisGlobal, United States
Associate Vice President, Safety
Kimberly Belsky
Mallinckrodt Pharmaceuticals
Executive Director, Regulatory Policy and Intelligence, Regulatory...
JB
Jasmine Benger
CISCRP
Research Services Senior Project Manager
Tyler Benning
Mayo Clinic
Medical Student
Robyn Bent
FDA, United States
Director, Patient Focused Drug Development Program, OCD, CDER
Aaron Berger
UBC, United States
Head of Evidence Development Solutions
EB
Elise Berliner
Agency For Healthcare Research and Quality (AHRQ)
Director, Technology Assessment Program
AB
Aaron Bernstein
Aaron Bernstein Consulting, LLC
Principal
Michael Berntgen
European Medicines Agency, Netherlands
Head of Scientific Evidence Generation
Amy Bertha
Bayer, United States
Executive Director, Regulatory Policy and Innovation
Melanie Bhatnagar
FDA
Associate Director for Pediatric Education & Outreach, OPT, OC
Barbara Bierer
Harvard Medical School, United States
Faculty Director, MRCT Center; Professor of Medicine
Claire Blanchette
Bayer
Vice President, Program Management - Oncogenic Signaling
Michael Blum
FDA, United States
Deputy Director, Office of Pharmacovigilance and Epidemiology, CDER
Ashley Boam
FDA, United States
Director, Office of Policy for Pharmaceutical Quality, OPQ, CDER
Mariette Boerstoel-Streefland
Alexion Pharmaceuticals, Inc.
Senior Vice President Global Drug Safety
Sébastien Bohn
IBM Watson Health
Offering Manager Executive
CB
Christopher Boone
AbbVie, United States
Vice President, Global Head, Health Economics and Outcomes Research
Poonam Bordoloi
Organon & Co., United States
Executive Director, Head of Global Medical Affairs Capabilities
Vanessa Boulanger
National Organization for Rare Disorders (NORD), United States
Director of Research Programs
Linda Bowen
Seagen Inc., United States
Head of Global Regulatory Policy and Intelligence
David Bowers
PPD, United States
Senior Director, Operations
Jim Box
SAS, United States
Principal Data Scientist for Life Sciences
Brian Bradbury
Amgen, United States
Vice President, Center for Observational Research
KB
Kate Bradford
Arena Pharmaceuticals
Head of International Field Based Medicine
Sonja Brajovic
FDA
Medical Officer, OSE, CDER
Jennifer Brandl
Kezar Life Sciences
Senior Clinical Trial Manager
KV
Kim Van Naarden Braun
Bristol-Myers Squibb Company
Associate Director, Translational Epidemiology, Informatics and...
Andrew Briggs
London School of Hygiene and Tropical Medicine (LSHTM)
Professor of Health Economics
Rachel Brodie
Pacific Business Group on Health
Senior Director, Measurement and Accountability
Philip (P.J.) Brooks
National Center for Advancing Translational Sciences (NCATS), NIH, United States
Program Director, Office of Rare Diseases Research
Sam De Brouwer
doc.ai
Cofounder and COO
Daniela Brunner
Science Forward/PsychoGenics
Founder/CIO
GB
Gillian Buckley
The National Academies of Sciences, Engineering, and Medicine
Senior Program Officer, Health and Medicine Division
Michael Buckley
Memorial Sloan Kettering Cancer Center
Manager, Clinical Research Informatics and Technology Enterprise...
Joan Buenconsejo
AstraZeneca
Senior Director, Biostatistics
Kevin Bugin
FDA, United States
Deputy Director of Operations, Office of New Drugs, CDER
Magda Bujar
Centre for Innovation in Regulatory Science (CIRS), United Kingdom
Senior Manager, Regulatory Programme and Strategic Partnerships
Kristin Bullok
Eli Lilly and Company, United States
Benefit-Risk Management Scientist, Global Patient Safety
Brandon Burch
Nuventra, Inc.
Associate Director, Scientific Writing and Regulatory Affairs
Jennifer Burgess
TransCelerate BioPharma, Inc., United States
Vice President, Global Engagement and Communications
SB
Scott Burian
Rho, Inc.
Senior Scientist
Victoria Burk
AbbVie, Inc.
Senior Director R&D Quality Assurance
LB
Lisa Burke
Rhythm
Senior Director, Field Medical
David Burrow
FDA, United States
Director, Office of Scientific Investigations, OC, CDER
Bill Byrom
Signant Health
Vice President, Product Strategy and Innovation
Gina Calarco
Covance
Director of Pediatric Strategy and Planning
Susan Callery-D'Amico
AbbVie, United States
Vice President, R&D Quality Assurance
Michelle Campbell
FDA, United States
Associate Director, Stakeholder Engagement and Clinical Outcomes, ON,...
Susan Cantrell
Academy of Managed Care Pharmacy (AMCP), United States
Chief Executive Officer
Yi Cao
Center for Food and Drug Inspection (CFDI)
Deputy Division Director, Div 4
Katherine Capperella
Janssen Pharmaceutical Companies of Johnson & Johnson
Global Patient Engagement Leader
NC
Nicholas Cappuccino
Dr. Reddy's Laboratories
Consultant, Compliance, Quality and Scientific Affairs
LC
Luca Cariolato
UBC
Senior Safety Scientist
Gillis Carrigan
Amgen, United States
Director, Center for Observational Research
Suzanne Caruso
WCG
Vice President, Clinical Solutions
Nina Cauchon
Amgen, United States
Director Regulatory Affairs CMC
Patrizia Cavazzoni
FDA, United States
Director, Center for Drug Evaluation
Catherine Celingant
Pfizer Inc
Oncology Therapeutic Area Lead, Data Monitoring and Management (DMM)
Aloka Chakravarty
FDA
Deputy Director, Office of Biostatistics, Office of Translational...
Meghana Chalasani
FDA, United States
Team Lead, Office of New Drugs, Center for Drug Evaluation and...
KC
Karen Chan
University of Southern California
Pharmacy Student
MC
May Chan-Liston
BMS
Global Risk Management Lead, Hematology and Cell Therapy
Andrew Chang
Novo Nordisk A/S, United States
Vice President, Quality and Regulatory Compliance
Lien-Cheng Chang
TFDA
Section Chief, Division of Medicinal Products
Pascal Chanu
Genentech, A Member of the Roche Group
Modeling and Simulation Expert
She-Chia Chen
FDA
ORISE Fellow, Office of Medication Error Prevention & Risk...
Ta-Jen Chen
FDA, United States
Project Management Officer, OSP, CDER
Yeh-Fong Chen
FDA
Mathematical Statistician (Team Lead), Office of Translational...
Monica Chiaramonte
AstraZeneca
Medical Communications Scientist
Karla Childers
Johnson & Johnson, United States
Head, Bioethics-based Science & Technology Policy
Jennifer Christian
IQVIA
Vice President, Clinical Evidence and Epidemiology
Leah Christl
Amgen, United States
Exec Director, Global Biosimilars Regulatory Affairs & Regulatory...
David Churchward
Medicines and Healthcare products Regulatory Agency (MHRA)
Deputy Unit Manager, Inspectorate Strategy and Innovation (Expert GMP...
Antony Chuter
Independent
Patient Champion
Jennifer Clark
FDA, United States
Mathematical Statistician, OB, OTS, CDER
Aria Cohen
Apellis Pharmaceuticals
Senior Director, US Market Access
Evi Cohen
Appian
Vice President, Global Life Sciences & Healthcare
Oren Cohen
Covance
Chief Medical Officer and Head of Clinical Pharmacology Services
Ellen Coleman
VOZ Advisors
President and CEO
Susan Colilla
Teva Pharmaceuticals
Director and Lead, Epidemiology and RWE
Sylva Collins
FDA, United States
Director, Office of Biostatistics, FDA, CDER
Seya Colloud
F. Hoffmann-La Roche Ltd
Global Regulatory Director
Deborah Collyar
Patient Advocates In Research (PAIR), United States
President
Michael Colopy
UCB Biosciences
Safety Statistics and Decision Scientist
Vivian Combs
Eli Lilly and Company, United States
Director of Scientific Communications
SC
Sabrina Comic-Savic
The Medicines Company
Vice President, Quality Assurance, Clinical Project Oversight
Gary Condran
Health Canada, Canada
Manager, Generic Drugs Quality Division, Bureau of Pharmaceutical...
Freda Cooner
Eli Lilly and Company, United States
Senior Director - Statistics
Stephen Joel Coons
Critical Path Institute
Executive Director, PRO Consortium
Fernanda Copeland
AVROBIO, Inc
Executive Director, Global Head of Patient Advocacy and Engagement
Charline Coquerel
Novo Nordisk A/S
Director, Global Patient Relations
MC
Madeline Corrigan
SmithSolve
Senior Account Manager
Christine Crandall
GlaxoSmithKline
Head of Clinical Project Management
Stephanie Crawford
University of Illinois at Chicago, United States
Professor, Pharmacy Systems, Outcomes and Policy
Donatello Crocetta
Takeda Pharmaceuticals International Gmbh
Global Medical Head, Rare Immunology and Rare Metabolic Franchises
Alysha Croker
Health Canada
Manager, Office of Paediatrics and Patient Involvement
Michelle Crouthamel
AbbVie, Inc., United States
Head, Digital Science, Global Clinical Development
William Crown
Optumlabs
Chief Scientific Officer
JC
Jonathan Crowther
Pfizer Inc
Director, Site Intelligence
Linda Danielson
IDDI Inc
Chief Operating Officer and Executive Vice President
Ebony Dashiell-Aje
Biomarin Pharmaceutical Inc.
Director, Patient-Centered Outcomes Research
Ruthie Davi
Medidata, a Dassault Systèmes company, United States
Vice President, Data Science and Statistician
Jeannie David
FDA
Senior Program Management Officer, Drug Shortage Staff, CDER
Patricia Davies
Parkinson's Foundation
Reasearch Advocate
Larry Davis
EVERSANA
Vice President, Medical and Clinical Affairs
Susan DeHaven
Sanofi
Director, Data Standards and Business Applications
Richard Dennett
PPD
Senior Director Regulatory Affairs CMC
Corey Dennis
Sanofi
Lead, US Privacy Officer
Frederick Derosier
Covance
Executive Director, Rare Diseases
SD
Sameen Desai
Bristol Myers Squibb
Senior Director, Pharmacovigilance Innovation
Shyam Deval
Boston Technology Corporation
President
Robert DiCicco
IBM Watson Health
Deputy Chief Health Officer
Michael DiMaio
Ropes & Gray LLP
Attorney
Arielle Dipasquale
Rutgers, The State University of New Jersey
PharmD Candidate, Class of 2021, Ernest Mario School of Pharmacy
Rachael DiSantostefano
Janssen Research & Development, LLC, United States
Senior Director, Epidemiology
SD
Sahith Doppalapudi
Bristol Myers Squibb
Manager, Safety Data Management and Analytics
Brian Dow
Janssen Research & Development, LLC
Scientist, Dossier Development and Operations
AnnCatherine Downing
Eli Lilly and Company
Senior Research Advisor - Clinical
Nicholas Drago
Bayer, United States
Associate Director, Global Regulatory Strategy
Nancy Dreyer
IQVIA, United States
Chief Scientific Officer & SVP
BD
Brian Dreyfus
Bristol-Myers Squibb Company, United States
Senior Director
João Duarte
Alexion, Astrazeneca Rare Disease, France
Director, Business Planning & Operations, Global Regulatory...
David Dubin
AliveandKickn
Founder
DD
David Dubinsky
Blueprint Medicine
Head of Global Patient Affairs
Shalini Dwivedi
Kinapse India Scientific Services Pvt. Ltd.
Director, Development Operations
Fabian D'Souza
Boston Strategic Partners, Inc, United States
Founder and President
Edye Edens
First Class Solutions, Inc.
Senior Research Compliance Consultant
Brian Egan
TransCelerate BioPharma Inc., United States
Senior Manager, Communications and Engagement
Falk Ehmann
European Medicines Agency
Chair of Innovation Task Force
Lukas Eichmann
Novo Nordisk
Associate Patient Relations Manager
Mary Elmer
Merck & Co., Inc., United States
Executive Director, Patient Engagement for Oncology
Jeff Elton
Concerto HealthAI
Chief Executive Officer
M. Khair ElZarrad
FDA, United States
Director, Office of Medical Policy, CDER
Sonya Eremenco
Critical Path Institute, United States
Director, PRO Consortium
Karen Erickson
Patient Advocate
CTTI Steering Committee Member
Sini Eskola
European Federation of Pharmaceutical Industries and Associations (EFPIA)
Director Regulatory Affairs
Harmonie Etienne
Dr. Ebeling & Assoc. GmbH
Pharmacovigilance Advisor
KE
Kathryn Evans
WCG Analgesic Solutions, United States
Associate Clinical Scientist
JF
John Farley
FDA, United States
Director, Office of Infectious Diseases, OND, CDER
Federico Feldstein
Johnson & Johnson, United States
Vice President, Global Head of R&D Quality Compliance
Kristen Felthousen
University of Southern California School of Pharmacy, United States
Program Administrator, Department of Regulatory and Quality Sciences
Phyllis Ferrell
Eli Lilly and Company
Global Head, External Engagement, Alzheimer's Disease and...
AF
Amy Fesmire-Baus
Bristol-Myers Squibb Company
Senior Medical Writer
DF
Daniel Fiebig
Rutgers University
Faculty
Ron Fitzmartin
FDA, United States
Senior Informatics Advisor, Office of Regulatory Operations, CBER
RF
Robert Fontana
University of Michigan
Professor of Medicine
Gail Francis
Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
Expert Inspector, GCP
Emily Freeman
Sanofi
Senior Director, Global Regulatory Behavioral Science
David Fryrear
Astellas, United States
Executive Vice President and Head of Quality Assurance
Yasuhiro Fujiwara
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Chief Executive
Andrea Furia-Helms
FDA, United States
Director, Office of Patient Affairs
MS
M. Scott Furness
FDA, United States
Deputy Director, Office of New Drug Products, OPQ, CDER
Sandra Gallagher
Viela Bio
Director of Project Management
Laura Galuchie
Merck & Co., Inc. (MSD outside US and Canada)
Director, Global Clinical Trial Operations
Shelley Gandhi
NDA Group
Strategic Advisor, Pharmacovigilance and Drug Safety
CG
Carlos Garner
Eli Lilly and Company
Vice-President Global Regulatory Affairs
Elizabeth Garner
ObsEva SA
Chief Medical Officer
Drew Garty
Veeva, United States
Chief Technology Officer, Vault CDMS
1
2
3
4